Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2007
08/16/2007WO2007090493A1 Indazole heteroaryl derivatives
08/16/2007WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
08/16/2007WO2007065261B1 Plasminogen activator inhibitor-1 inhibitors
08/16/2007WO2007026959A3 Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders
08/16/2007WO2006103449A3 Saminopyrimidine derivates with tie2 inhibiting activity
08/16/2007WO2005120186A3 Methyl 2,4,9-trithiaadamantane-7-carboxylate
08/16/2007US20070191423 Isoquinoline derivatives
08/16/2007US20070191420 Kinase inhibitors
08/16/2007US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
08/16/2007US20070191343 4-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewith
08/16/2007US20070191341 N-Substituted Benzene Sulfonamides
08/16/2007US20070190041 Novel benzothiazepine and bensothiepine compounds
08/16/2007US20070189967 a mixture of a benzofuran derivatives such as [2-(2-formyl-5-furanyl)-3-hydroxymethyl benzofuran], and a label selected from radioisotopes, paramagnetic particles and optical particles, used for in vivo and in vitro detection beta-amyloid in a sample of brain tissues; noninvasive medical diagnosis
08/16/2007DE102006005937A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis
08/16/2007CA2641350A1 Aminoindazole derivatives
08/16/2007CA2641347A1 Indazole-heteroaryl derivatives
08/16/2007CA2637768A1 Benzamide and heteroarene derivatives
08/16/2007CA2635138A1 Piperidine derivatives as cxcr3 receptor antagonists
08/16/2007CA2629336A1 [4-(benzo[b]thiophen-2-yl)pyrimidin-2yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
08/15/2007EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1817834A1 Method and installation means for installing an electrical machine
08/15/2007EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors
08/15/2007EP1817309A1 Acetamide compounds as fungicides
08/15/2007EP1817306A1 Triazoles and their use as bradykinin b1 receptor antagonists
08/15/2007EP1817294A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders
08/15/2007EP1817292A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
08/15/2007EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors
08/15/2007EP1817285A2 Cycloalkyl keto piperidine tachykinin receptor antagonists
08/15/2007EP1817283A1 2-substituted indoles, their precursors and novel processes for the preparation thereof
08/15/2007EP1817030A2 Inducible nitric oxide synthase dimerization inhibitors
08/15/2007EP1597235B1 Non-nucleoside reverse transcriptase inhibitors
08/15/2007EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists
08/15/2007EP1440069B1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
08/15/2007EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
08/15/2007EP1192149B1 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/15/2007CN1331853C Small molecule inhibitors of rotamase enzyme activity
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN101018783A Quinoxaline inhibitors of the HEDGEHOG signalling pathway
08/15/2007CN101018782A Hydantoin compound for the treatment of inflammatory disorders
08/15/2007CN101018774A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
08/15/2007CN101018552A Intracellular receptor modulator compounds and methods
08/15/2007CN101016296A Muscarinic agonists
08/15/2007CN101016264A Nitroimidazole derivative for treatment, preparing method and use
08/14/2007US7256213 Taxanes having a C10 carbonate substituent
08/14/2007US7256203 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
08/14/2007US7256201 Selective estrogen receptor-β ligands
08/14/2007US7256199 2-(Substituted amino)-6-(4-pyridyl)pyrimidin-4-ones, e.g., 2-(N-phenylamino)-6-(4-pyridyl)pyrimidin-4-one and 2-(N-(3-bromophenyl)amino)-6-(4-pyridyl)pyrimidin-4-one; treatment of diseases caused by tau protein kinase 1 hyperactivity such as Alzheimer disease.
08/14/2007US7256158 Animal husbandry; veterinary medicine
08/14/2007CA2281708C Process for preparing eprosartan
08/09/2007WO2007089669A2 Processes for the preparation of compounds which modulate cell proliferation
08/09/2007WO2007089626A2 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/09/2007WO2007089044A1 Process for production of aromatic compound
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088876A1 Pyridone derivative and herbicide
08/09/2007WO2007088181A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
08/09/2007WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
08/09/2007WO2007059952A3 1-benzazepine-3-sulfonylamino-2-pyrrloridones as factor xa inhibitors
08/09/2007WO2007044729A3 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
08/09/2007WO2006119400A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
08/09/2007US20070185334 pyrazole compound (e.g. 5-hydroxy-3-trifluoromethylpyrazole) is reacted with a sulfur compound (e.g. 2-ethylthiophenol) in the presence of a base and formaldehyde, to produce a 5-hydroxy-4-thiomethylpyrazole
08/09/2007US20070185332 Made by reacting a cyano compound with a silylalkylisocyanide compound; silylimidazole ;
08/09/2007US20070185326 Heterocyclic compound
08/09/2007US20070185207 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185168 Piperidine derivatives
08/09/2007US20070185163 Imidazol derivatives of piperidine as histamine antagonists
08/09/2007US20070185161 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
08/09/2007US20070185158 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185152 Inhibitors of akt activity
08/09/2007US20070185126 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing Them
08/09/2007US20070185119 Therapeutic agents II
08/09/2007US20070185116 Bicyclic compounds
08/09/2007US20070185092 FACTOR Xa INHIBITORS
08/09/2007US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
08/09/2007US20070185079 Therapeutic agents I
08/09/2007US20070185063 Seven-membered ring nucleosides
08/09/2007US20070184979 Novel sulfonylpyrroles
08/09/2007DE102006005180A1 Indazol-heteroaryl-derivate Indazole-heteroaryl derivatives
08/09/2007DE102006005179A1 Aminoindazolderivate Aminoindazolderivate
08/09/2007CA2641817A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparation
08/09/2007CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
08/09/2007CA2637545A1 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/08/2007EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists
08/08/2007EP1814876A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease
08/08/2007EP1814874A1 N-heterocyclyl phthalic acid diamides as insecticides
08/08/2007EP1814872A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases
08/08/2007EP1814866A2 Gonadotropin releasing hormone receptor antagonists
08/08/2007EP1814864A1 Nitro indazole derivatives
08/08/2007EP1814863A1 Indazole sulphonamide derivatives
08/08/2007EP1814861A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
08/08/2007EP1814857A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
08/08/2007EP1814850A1 New histone deacetylases inhibitors
08/08/2007EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/08/2007EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors
08/08/2007EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid
08/08/2007EP0980867B1 Ketone derivatives and medicinal use thereof
08/08/2007CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives
08/08/2007CN101014612A Compounds for proteasome enzyme inhibition
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 523